Literature DB >> 29476330

Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Alain Braillon1, Francoise Taiebi2,3, Amal Bernoussi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29476330     DOI： 10.1007/s40261-018-0628-2

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  12 in total

1.  The long-term effect of a population-based life-style intervention on smoking and alcohol consumption. The Inter99 Study--a randomized controlled trial.

Authors:  Sophie Baumann; Ulla Toft; Mette Aadahl; Torben Jørgensen; Charlotta Pisinger
Journal:  Addiction       Date:  2015-08-19       Impact factor: 6.526

2.  Nalmefene for alcohol dependence: a NICE decision?

Authors:  Florian Naudet; Niamh Fitzgerald; Alain Braillon
Journal:  Lancet Psychiatry       Date:  2016-12       Impact factor: 27.083

3.  Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency.

Authors:  Alain Braillon
Journal:  BMJ       Date:  2014-03-10

Review 4.  Bad medicine: nalmefene in alcohol misuse.

Authors:  Des Spence
Journal:  BMJ       Date:  2014-02-14

5.  Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.

Authors:  Clément Palpacuer; Renan Duprez; Alexandre Huneau; Clara Locher; Rémy Boussageon; Bruno Laviolle; Florian Naudet
Journal:  Addiction       Date:  2017-09-20       Impact factor: 6.526

Review 6.  Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Matt Stevenson; Abdullah Pandor; John W Stevens; Andrew Rawdin; Peter Rice; Jez Thompson; Marsha Y Morgan
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

7.  Controlled drinking by alcoholics? New findings and a reevaluation of a major affirmative study.

Authors:  M L Pendery; I M Maltzman; L J West
Journal:  Science       Date:  1982-07-09       Impact factor: 47.728

Review 8.  Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Authors:  Clément Palpacuer; Bruno Laviolle; Rémy Boussageon; Jean Michel Reymann; Eric Bellissant; Florian Naudet
Journal:  PLoS Med       Date:  2015-12-22       Impact factor: 11.069

9.  Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?

Authors:  Alain Braillon; Bernard Granger
Journal:  Subst Abuse Rehabil       Date:  2015-06-29

Review 10.  Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.

Authors:  Niamh Fitzgerald; Kathryn Angus; Andrew Elders; Marisa de Andrade; Duncan Raistrick; Nick Heather; Jim McCambridge
Journal:  Addiction       Date:  2016-06-05       Impact factor: 6.526
View more
  1 in total

1.  Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Authors:  Pablo Barrio; Lluisa Ortega; Josep Guardia; Carlos Roncero; Lara Yuguero; Antoni Gual
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.